Skip to content

US Signs $11 Million Deal to Fund Monkeypox Vaccines

  • Funding will help Michigan company finish vaccine vials
  • US production seen helping to secure country’s supply chain
Monkeypox vaccine vials from Bavarian Nordic. 

Monkeypox vaccine vials from Bavarian Nordic. 

Photographer: Pascal Guyot/AFP/Getty Images

The Biden administration signed an $11 million deal to support a Michigan company that’s helping make vaccine against monkeypox, another move to bolster prevention of the quickly spreading virus. 

The Health and Human Services Department’s Biomedical Advanced Research and Development Authority is providing the funding to help Grand River Aseptic Manufacturing Inc. acquire equipment and personnel to finish manufacturing 2.5 million monkeypox vaccine vials, according to details of the agreement viewed by Bloomberg. Grand River agreed in August with Bavarian Nordic A/S, the shot’s maker, to fill and finish the vials.